Non-invasive ventilation in severe acute respiratory failure complicating Madelung’s disease: a case series and management review - Top-Institutions - MDSpire

Application of Non-Invasive Ventilation in Severe Acute Respiratory Failure Associated with Madelung’s Disease: A Case Series and Management Analysis

  • By

  • Bruno Gomes

  • Antonio M. Esquinas

  • Fares N. Alwajeeh

  • June 4, 2026

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Pulmonology
    • Critical Care

  • #2

    UCLA Health (Ronald Reagan UCLA Medical Center)
    UCLA Health (Ronald Reagan UCLA Medical Center)

    Los Angeles, California

    Key Differentiators

    • Pulmonology
    • Critical Care

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pulmonology
    • Critical Care

  • #4

    ARDS Network
    ARDS Network

    N/A, N/A

    Key Differentiators

    • Pulmonology
    • Critical Care

  • #5

    International Severe Acute Respiratory and Emerging Infection (ISARIC)
    International Severe Acute Respiratory and Emerging Infection (ISARIC)

    N/A, N/A

    Key Differentiators

    • Pulmonology
    • Infectious Disease

Original Source(s)

Non-invasive ventilation in severe acute respiratory failure complicating Madelung’s disease: a case series and management review

  • by Bruno Gomes, Antonio M. Esquinas, Fares N. Alwajeeh

  • June 4, 2026

Related Content

Renin and 1-year mortality in critically ill patients with ARDS: trajectories, discrimination, and survival analysis

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.